Kyverna Therapeutics, Inc.

Kyverna Therapeutics is a drug development company working on treatments for autoimmune diseases, conditions where the body's immune system mistakenly attacks itself. Their approach uses cell therapy, which means they take immune cells from patients, modify them to attack disease-causing cells, and put them back. The company is in late-stage testing of their main product for diseases like stiff person syndrome and myasthenia gravis, and they are also developing versions that could work from donated cells rather than a patient's own cells.